Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daflon for radiation proctitis
2019-001916-44Phase 3Terminated
- Sponsor
- Medical University of Innsbruck
- Start
- Jan 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in radiation proctitis comparing Daflon with Placebo (2 arms). Primary endpoint: number of necessary interventions within 1 year. Started Jan 2020; status: terminated.
02
Drugs
diosmin
03
Conditions
radiation proctitis
Beyond the preview
Go deeper on 2019-001916-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001916-44.